JL

Jeremy Levin

Opthea Limited | Non-Executive Chairman, Non-Executive Director
Dr. Levin has served as the Chief Executive Officer of Ovid Therapeutics Inc. since 2015, and since 2014, as Chairperson of the board of directors, of Ovid. From May 2012 to October 2013, Dr. Levin served as the President and Chief Executive Officer of Teva Pharmaceutical Industries Ltd., a publicly held pharmaceutical company. From September 2007 to December 2012, Dr. Levin held several roles at Bristol Myers Squibb Company, a publicly held pharmaceutical company, ultimately serving as the Senior Vice President of Strategy, Alliances and Transactions. Dr. Levin also served as a member of the executive committee at Bristol Myers Squibb Company.

Company and Roles

Company
Title
Tenure
Since
OPT
OPT
Opthea Limited
  • Non-Executive Chairman
  • Non-Executive Director
4yrs, 5mthOct 2020

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
OPT
OPT
Opthea Limited
17/12/2431,496N/A8,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
OPT
OPT
Opthea Limited
17/12/24
Issued
2,000,000$0.635$1,270,000Issue of options
OPT
OPT
Opthea Limited
21/12/23
Issued
3,000,000$0.470$1,410,000Issue of options
OPT
OPT
Opthea Limited
01/03/21
Issued
3,000,000$1.580$4,740,000Issue of options